32.93
+0.03
+(0.09%)
As of 8:10:53 AM GMT+2. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHENG ANDREW Chief Executive Officer | Sale | Mar 12, 2025 | 654,324 |
| GANGLOFF SCOTT A. Chief Technology Officer | Stock Award(Grant) | Dec 16, 2024 | 24,300 |
| GRAHAM G. WALMSLEY Director | Purchase | Mar 27, 2025 | -- |
| HENDERSON JANE Director | Sale | Jun 16, 2023 | 0 |
| HEYMAN TOMAS J. Director | Sale | Jun 16, 2023 | 0 |
| LAMY PATRICK Officer | Sale | Mar 3, 2025 | 33,492 |
| ROLPH TIMOTHY PETER Officer | Sale | Apr 7, 2025 | 169,721 |
| WHITE WILLIAM RICHARD Chief Financial Officer | Sale | Mar 12, 2025 | 61,959 |
| YALE CATRIONA Officer | Sale | Mar 17, 2025 | 95,034 |
| YOUNG JONATHAN Chief Operating Officer | Sale | Mar 12, 2025 | 260,540 |
Related Tickers
1FW2.F WuXi Biologics (Cayman) Inc.
2.2410
-7.95%
VT6.F Voyager Therapeutics, Inc.
2.5000
-10.65%
8EM.F Editas Medicine, Inc.
1.0880
-1.94%
VLA.VI Valneva SE
3.1320
+1.56%
IVA.PA Inventiva S.A.
2.8450
+0.18%
AKTX Akari Therapeutics, Plc
1.1988
+8.00%
CYCN Cyclerion Therapeutics, Inc.
2.6900
-5.61%
22UA.DE BioNTech SE
87.60
-0.51%
RZLT Rezolute, Inc.
2.6200
+1.95%
GLYC GlycoMimetics, Inc.
0.2278
+2.61%